EASD 2023 Endobarrier 1068 patients treated worldwide - Poster

Duodenal Jejunal Bypass Liner (DJBL) treatment for type 2 diabetes and obesity: glycaemic and CVD risk factor improvements vs risks among 1068 patients treated worldwide.

Authors: 
R.E.J. Ryder, J. Stein, T. Battelino, J. Teare, A. Ruban, H. Frydenberg, L. Munro, S. Fishman, R. Cohen, C. de Jonge, J.-W. Greve, H. Sourij, P. Sen Gupta1, K. Laubner, J. Seufert.